Vaxart annual debt-to-assets ratio
2017
2018
2019
2020
2021
2022
2023
2024
2025
Vaxart's debt-to-assets ratio was 0.05 for fiscal 2025.
View full Vaxart company overview| Fiscal year | Period ended | Debt-to-assets ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.05 | −0.06 | −54.16% |
| 2024 | 2024-12-31 | 0.11 | −0.11 | −51.85% |
| 2023 | 2023-12-31 | 0.22 | 0.08 | +55.05% |
| 2022 | 2022-12-31 | 0.14 | 0.08 | +139.87% |
| 2021 | 2021-12-31 | 0.06 | 0.01 | +24.50% |
| 2020 | 2020-12-31 | 0.05 | −0.02 | −24.37% |
| 2019 | 2019-12-31 | 0.06 | −0.44 | −87.60% |
| 2018 | 2018-12-31 | 0.50 | −3.01 | −85.67% |
| 2017 · Dec 31 | 2017-12-31 | 3.52 | — | — |
| Fiscal quarter | Period ended | Debt-to-assets ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 0.05 | −0.05 | −51.87% |
| Q1 2026 | 2026-03-31 | 0.04 | −0.06 | −58.30% |
| Q4 2025 | 2025-12-31 | 0.05 | −0.06 | −54.16% |
| Q3 2025 | 2025-09-30 | 0.07 | −0.04 | −32.33% |
| Q2 2025 | 2025-06-30 | 0.10 | −0.07 | −40.76% |
| Q1 2025 | 2025-03-31 | 0.11 | −0.11 | −51.72% |
| Q4 2024 | 2024-12-31 | 0.11 | −0.11 | −51.85% |
| Q3 2024 | 2024-09-30 | 0.11 | −0.08 | −43.61% |
| Q2 2024 | 2024-06-30 | 0.17 | −0.01 | −3.17% |
| Q1 2024 | 2024-03-31 | 0.22 | 0.05 | +32.65% |
| Q4 2023 | 2023-12-31 | 0.22 | 0.08 | +55.05% |
| Q3 2023 | 2023-09-30 | 0.19 | 0.07 | +53.15% |
| Q2 2023 | 2023-06-30 | 0.17 | 0.10 | +144.99% |
| Q1 2023 | 2023-03-31 | 0.17 | 0.10 | +157.06% |
| Q4 2022 | 2022-12-31 | 0.14 | 0.08 | +139.87% |
| Q3 2022 | 2022-09-30 | 0.13 | 0.07 | +139.30% |
| Q2 2022 | 2022-06-30 | 0.07 | 0.04 | +159.84% |
| Q1 2022 | 2022-03-31 | 0.06 | 0.03 | +100.03% |
| Q4 2021 | 2021-12-31 | 0.06 | 0.01 | +24.50% |
| Q3 2021 | 2021-09-30 | 0.05 | 0.04 | +199.35% |
| Q2 2021 | 2021-06-30 | 0.03 | −0.00 | −10.28% |
| Q1 2021 | 2021-03-31 | 0.03 | −0.01 | −20.33% |
| Q4 2020 | 2020-12-31 | 0.05 | −0.02 | −24.37% |
| Q3 2020 | 2020-09-30 | 0.02 | −0.04 | −70.02% |
| Q2 2020 | 2020-06-30 | 0.03 | 0.01 | +42.96% |
| Q1 2020 | 2020-03-31 | 0.04 | 0.01 | +45.55% |
| Q4 2019 | 2019-12-31 | 0.06 | −0.44 | −87.60% |
| Q3 2019 | 2019-09-30 | 0.06 | −0.37 | −86.39% |
| Q2 2019 | 2019-06-30 | 0.02 | −0.34 | −94.13% |
| Q1 2019 | 2019-03-31 | 0.03 | — | — |
| Q4 2018 | 2018-12-31 | 0.50 | −3.01 | −85.67% |
| Q3 2018 | 2018-09-30 | 0.43 | — | — |
| Q2 2018 | 2018-06-30 | 0.36 | — | — |
| Q4 2017 · Dec 31 | 2017-12-31 | 3.52 | — | — |
Over the last five fiscal years, Vaxart's debt-to-assets ratio increased from 0.05 to 0.05, a change of 0.00. The latest reported quarter, Q2 2026, shows 0.05.
The debt-to-assets ratio shows the portion of a company’s reported assets financed with interest-bearing debt. It is a leverage measure and should not be confused with total liabilities divided by assets.
TickerStat calculates debt-to-assets as total interest-bearing debt divided by total assets at the same reporting-period end. Periods with missing debt or non-positive assets are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Vaxart source filings ↗